This inventor holds 4 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignee: The Board of Regents of the University of Nebraska. Active years: 2019-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019-2024
Title: Innovations of Xiaobei Wang in Glucocorticoid Prodrugs
Introduction
Xiaobei Wang is a notable inventor based in Omaha, NE (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of glucocorticoid prodrugs. With a total of 4 patents to his name, Wang's work focuses on innovative methods for treating various diseases and disorders.
Latest Patents
Wang's latest patents include the development of polyethylene glycol (PEG)-conjugated glucocorticoid prodrugs. These patents disclose methods of preparation and use for the treatment of diseases, particularly inflammatory and autoimmune diseases such as lupus. The PEG-conjugated dexamethasone compounds he has developed offer promising therapeutic options for patients suffering from these conditions.
Career Highlights
Xiaobei Wang is affiliated with the Board of Regents of the University of Nebraska, where he continues to advance his research and innovations. His work has garnered attention for its potential impact on medical treatments and patient care.
Collaborations
Wang collaborates with esteemed colleagues, including Dong Wang and Zhenshan Jia, contributing to a dynamic research environment that fosters innovation and discovery.
Conclusion
Xiaobei Wang's contributions to the field of glucocorticoid prodrugs exemplify the importance of innovation in medicine. His work not only enhances our understanding of treatment options but also paves the way for future advancements in pharmaceutical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile